Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Aggregator Full Text
  • MESH
  • Antiviral Agents
  • Drug Therapy
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Incidence
  • Survival Analysis
  • Treatment Outcome

Unbound MEDLINE

The drugs can work.

Abstract

There are signs that the therapeutic successes that have contributed to the downward trajectory for HIV-1 mortality may soon be repeated for HCV.

Links

  • Aggregator Full Text
  • Source

    Nature reviews. Microbiology 10:5 2012 May pg 307

    MeSH

    Antiviral Agents
    Drug Therapy
    Hepacivirus
    Hepatitis C
    Humans
    Incidence
    Survival Analysis
    Treatment Outcome

    Pub Type(s)

    Editorial

    Language

    eng

    PubMed ID

    22629548

    Related Citations

    • New frontiers of HCV therapy in HIV/HCV co-infection.
    • Hepatitis: HCV virologic response--new nomenclature recommendations.
    • Clinical trial investigates two experimental HCV drugs.
    • The design of drugs for HIV and HCV.
    • Development of novel treatments for hepatitis C.
    • Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.
    • [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
    • HCV and HIV: a tale of two viruses.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved